*Some Market data delayed by 15 mins.

Sonnet BioTherapeutics Holdings, Inc. Common Stock

Symbol: SONN (NASDAQ)
1.59 ▼ (-3.64%) -0.060

Company Description:
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Key Stats
  • Today's Open: $1.65
  • Today's High: $1.81
  • Today's Low: $1.57
  • Today's Volume: 18.01K
  • Yesterday Close: $1.65
  • Yesterday High: $1.85
  • Yesterday Low: $1.63
  • Yesterday Volume: 10.87K
  • Last Min Volume: 0
  • Last Min High: $1.593
  • Last Min Low: $1.59
  • Last Min VWAP: $0
Company Profile
  • Name: Sonnet BioTherapeutics Holdings, Inc. Common Stock
  • Website: https://www.sonnetbio.com
  • Listed Date: 2020-04-01
  • Location: PRINCETON, NJ
  • Market Status: Active
  • CIK Number: 0001106838
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $4.92M
  • Round Lot: 100
  • Outstanding Shares: 3.11M
  • Asset Type: CS
RECENT FILINGS FOR SONN
Filing DateFiling TypeFormat
2024-06-148-KView
2024-06-138-KView
2024-05-228-KView
2024-05-208-KView
2024-05-16EFFECTView
2024-05-16424B3View
2024-05-15CORRESPView
2024-05-15S-1/AView
2024-05-148-KView
2024-05-148-KView
2024-05-1410-QView
2024-05-09UPLOADView
2024-05-03S-1View
2024-05-038-KView
2024-03-118-KView
2024-03-068-KView
2024-02-148-KView
2024-02-1410-QView
2024-02-018-KView
2024-01-298-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.